First human tests begin for potential cystic fibrosis drug
NCT ID NCT07283770
Summary
This is a very early study to check if a new drug called VX-581 is safe and how it moves through the body. It involves 128 healthy volunteers who will receive either the drug or a placebo. The main goal is to understand the drug's safety profile and how the body processes it before testing it in people with cystic fibrosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences - Kansas City
RECRUITINGOverland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.